PRINCIPIA BIOPHARMA
HQ - San Francisco
Summary
Principia Biopharma operates as a clinical stage biopharmaceutical company. The Company offers reversible covalent small molecule drugs for the treatment of cancers. Principia Biopharma serves patients in the United States.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 2.75 B
Avg. Deal Size£ 2.75 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
